Trial intelligence / Profile preview

Safety and Immunological Responses after COVID-19 Vaccination in Thai Pregnant Women

TCTR20210717002Phase 4Completed

Sponsor
National Research Council of Thailand
Start
Aug 2021
Countries
1
01

Overview

Phase 4, open-label, single-arm trial in coronavirus disease 2019 (COVID-19), sponsored by National Research Council of Thailand. Primary endpoints: Safety outcomes and Immunological responses. Started Aug 2021; status: completed.

02

Conditions

coronavirus disease 2019 (COVID-19)

Beyond the preview

Go deeper on TCTR20210717002.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20210717002.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call